Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Caitlin Ray

2PUBLICATIONS

27CO-AUTHORS

Infectious diseasesInnate immunity

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Apr 04, 2025

Patterns in Prescribing and Dispensing Influenza Antivirals Among Adults With Influenza Presenting to Urgent Care and Emergency Department Settings: VISION Network, 2023-2024.

Katherine Adams, Shikha Garg, Sara Y Tartof

|Dec 10, 2024

Influenza Vaccine Effectiveness Against Hospitalizations and Emergency Department or Urgent Care Encounters for Children, Adolescents, and Adults During the 2023-2024 Season, United States.

Mark W Tenforde, Emily L Reeves, Zachary A Weber

Pageof 1

Frequent Collaborators

2 joint publications

Mark W Tenforde

2 joint publications

Shikha Garg

2 joint publications

Kristin Dascomb

2 joint publications

Varsha Neelam

2 joint publications

Katherine Adams

2 joint publications

Inih J Essien

2 joint publications

Ruth Link-Gelles

2 joint publications

Ousseny Zerbo

2 joint publications

Bruno Lewin

1 joint publications

Duck-Hye Yang

Frequent Collaborators

2 joint publications

Mark W Tenforde

2 joint publications

Shikha Garg

2 joint publications

Kristin Dascomb

2 joint publications

Varsha Neelam

Top Related Videos

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on : Apr 15, 2017

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on : Dec 01, 2017

See more related videos

Top Related Videos

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on : Apr 15, 2017

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on : Dec 01, 2017

See more related videos